About Adem Albayrak
Adem Albayrak is a chief data & AI officer at Alzheon.
Adem Albayrak first appears on SEC filings in 2024.
Experience
This experience comes from Adem Albayrak's profile and from SEC filings. For roles taken from filings, the years are when the filings name Adem Albayrak in the role, so the role may have started earlier or lasted longer.
Alzheon, Inc. Current
Chief Data & AI Officer
2021 – Present · Framingham, MA
Develops investigational medicines for people with Alzheimer’s and other neurodegenerative disorders.
HC
Health Catalyst
SVP of Technology, Life Sciences Business
2019 – 2021
DI
Dana-Farber Cancer Institute
Informatics Consultant
2018 – 2020
MB
Mass General Brigham
Corporate Team Leader, Bioinformatics & Business Analysis at Dana-Farber Cancer Institute
2014 – 2018
BQ
BIOBASE - Acquired by QIAGEN
Product Manager, Human Mutation and Variant Analysis
2013 – 2014
KI
Knome Inc
Software Product Developer / Product Manager
2010 – 2012
UC
United States Marine Corps
Sergeant
2003 – 2011
IR
Institute for Visualization and Perception Research
Research Assistant
2008 – 2010
Key Colleagues at Startups
The people Adem Albayrak works with at each company, as listed on that company's latest Form D.
Alzheon, Inc. · Form D, Sep 10, 2026
Christopher Dunn
Director
Neil Flanzraich
Executive Chairman of the Board of Directors
Diane Jorkasky, M.D.
Director
JD
John Hey, Ph.D.
Chief Scientific Officer
SD
Susan Abushakra, M.D.
Chief Medical Officer
MS
Muneer Satter
Director
Jordan Heller
Director
AM
Aidan Power, MRCPsych
Chief Development Officer
Gino Santini
Director
Kenneth Mace
Chief Financial Officer
MD
Martin Tolar, M.D., Ph.D.
Founder, President & CEO, director